Another study also constructed a ceRNA network related to HCC recurrence, and revealed that four mRNAs (ADH4, DNASE1L3, HGFAC and MELK) could be used as potential biomarkers for HCC recurrence prediction and targeted therapies [12]. This evidence concerns the gene ADH4 and hepatocellular carcinoma.